A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

NCT00000737 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Cachexia
HIV Infections
HIV Wasting Syndrome

Interventions

DRUG: Dronabinol
DRUG: Megestrol acetate

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]